Compare PTGX & SPNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PTGX | SPNS |
|---|---|---|
| Founded | 2006 | 1982 |
| Country | United States | Israel |
| Employees | N/A | 4850 |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.4B | 2.4B |
| IPO Year | 2016 | 1992 |
| Metric | PTGX | SPNS |
|---|---|---|
| Price | $85.94 | $43.45 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 9 | 3 |
| Target Price | ★ $90.56 | $31.33 |
| AVG Volume (30 Days) | ★ 1.1M | 556.5K |
| Earning Date | 11-06-2025 | 11-13-2025 |
| Dividend Yield | N/A | ★ 1.38% |
| EPS Growth | N/A | ★ N/A |
| EPS | 0.72 | ★ 1.15 |
| Revenue | $209,217,000.00 | ★ $564,331,000.00 |
| Revenue This Year | N/A | $8.80 |
| Revenue Next Year | $296.47 | $6.98 |
| P/E Ratio | $119.12 | ★ $37.78 |
| Revenue Growth | N/A | ★ 4.71 |
| 52 Week Low | $33.70 | $23.69 |
| 52 Week High | $96.54 | $43.52 |
| Indicator | PTGX | SPNS |
|---|---|---|
| Relative Strength Index (RSI) | 46.85 | 71.89 |
| Support Level | $84.11 | $43.27 |
| Resistance Level | $96.54 | $43.52 |
| Average True Range (ATR) | 3.32 | 0.06 |
| MACD | -0.89 | 0.01 |
| Stochastic Oscillator | 16.28 | 82.91 |
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.
Sapiens International Corp NV is a provider of software solutions for the insurance industry, with an emerging focus on the financial services sector. The company offers software, solutions, and professional services for property & casualty (P&C); reinsurance; life, pension & annuity (L&A); workers' compensation (WC); medical professional liability (MPL); financial & compliance (F&C); and decision modeling for both insurance and financial markets. The group also provides services for project delivery and implementation services, for its Software Solutions portfolio. Geographically, it operates in the region of North America, Rest of the World, and Europe. It generates revenue from Europe.